http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102060845-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99bba39dc2059db24e12338c69134265 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 |
| filingDate | 2010-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b64db2a773989155b4d99ba4458e1543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a904b3d001d4f76fefc04c4baf916083 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3ff38143deca2a5275ecf47b3dde9a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eb657b90d0821dedb6ff3329ec90f3d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f49b96f4ba4e07b7c85a672c98cfd06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ecf917138d8e7558ac5e1da34f97f53 |
| publicationDate | 2013-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102060845-B |
| titleOfInvention | Fasudil crystal formation III as well as preparation method and application thereof |
| abstract | The invention particularly relates to a Fasudil crystal formation III as well as a preparation method and application thereof, belonging to the technical field of medicines. For the Fasudil hydrochloride V crystal formation, Cu-Ka radiation is adopted, and X-ray powder represented by an angle of 2 theta is diffracted by angles of 6.480, 13.620, 14.780, 16.700, 20.500, 20.800, 21.540, 24.580 and 25.540 degrees, wherein the angle of 2 theta has a characteristic peak. The Fasudil hydrochloride crystal formation prepared with the preparation method provided by the invention has the advantages of high bioavailability, obvious drug effect, good stability, high yield rate, high purity and the like, and is suitable for industrial production. The invention also further discloses the application of the Fasudil hydrochloride in improving and preventing of ischemic cranial vascular diseases caused by various reasons. |
| priorityDate | 2010-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.